Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome (Q34883323)

From Wikidata
Jump to navigation Jump to search
scholarly article
edit
Language Label Description Also known as
English
Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome
scholarly article

    Statements

    Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome (English)
    Piotr Religa
    Anker Jon Hansen
    Franco Lucchini
    Bernt Jones
    Zhenping Zhu
    Bronislaw Pytowski
    Yuxiang Liang
    Weide Zhong
    Paolo Vezzoni
    18 November 2008
    18513-18518

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit